Monoclonal Antibodies in the Treatment of Systemic Lupus Erythematosus

E-ISSN： 1873-5592|10|1|26-37

ISSN： 1389-4501

Source： Current Drug Targets, Vol.10, Iss.1, 2009-01, pp. : 26-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dehydroepiandrosterone for the treatment of systemic lupus erythematosus

By van Vollenhoven Ronald F

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 1, 2002-01 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite

Treatment Options for Juvenile-Onset Systemic Lupus Erythematosus

By Carreño L. López-Longo F.J. González C.M. Monteagudo I.

Pediatric Drugs, Vol. 4, Iss. 4, 2002-01 ,pp. : 241-256

Adis International

Access to resources Recommend Favorite

New therapies for the treatment of systemic lupus erythematosus

By Gullick Dr Nicola D’Cruz Dr David

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 3, 2007-03 ,pp. : 299-313

Informa Healthcare

Access to resources Recommend Favorite

An Insight on the Pathogenesis and Treatment of Systemic Lupus Erythematosus

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 2, 2018-02 ,pp. : 110-123

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy of systemic lupus erythematosus

By Francis Lisa Perl Andras

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1481-1494

Informa Healthcare

Access to resources Recommend Favorite